Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bull 2X Shares

32.80
-0.3651-1.10%
Volume:24.46K
Turnover:794.28K
Market Cap:18.04M
PE:- -
High:33.17
Open:33.17
Low:31.90
Close:33.17
52wk High:35.13
52wk Low:14.58
Shares:550.00K
Float Shares:550.00K
Volume Ratio:0.29
T/O Rate:4.45%
Dividend:3.17
Dividend Rate:9.65%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly Outlook FY Revenue USD 85,000-87,000 Million

THOMSON REUTERS
·
Aug 05

Eli Lilly: Asset Impairment, Restructuring and Other Special Charges of $703 Mln in Q2 2026

THOMSON REUTERS
·
Aug 05

Lilly Q2 Mounjaro Revenue USD 9,943 Million

THOMSON REUTERS
·
Aug 05

Lilly - Q2 U.S. Zepbound Revenue Increased 44% to $4.9 Billion

THOMSON REUTERS
·
Aug 05

Lilly Outlook FY Adjusted EPS USD 35.5-36.5

THOMSON REUTERS
·
Aug 05

CVS Health Raises Earnings Outlook and Launches Lilly Partnership. the Stock Jumps.

Dow Jones
·
Aug 05

Morning BID Americas-Outer SpaceX

Reuters
·
Aug 05

CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as 2Q Profit Increases

Dow Jones
·
Aug 05

CVS Health Corp: Co & Lilly Collaborating to Help Eligible Zepbound and Foundayo Patients More Easily Access Transparent Pricing

THOMSON REUTERS
·
Aug 05

European Shares Hover Near Record Highs as Earnings Offset Mideast Uncertainty

Reuters
·
Aug 05

Novo CEO Looks to Speed up R&D as Share Drop Shows Gap with Lilly

Reuters
·
Aug 05

AMD, Walt Disney And 3 Stocks To Watch Heading Into Wednesday

Benzinga Earnings
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Sandoz Gains on Strong Biosimilar Growth, Touts 'golden Decade'

Reuters
·
Aug 05

Suncoast Equity Management trims Eli Lilly position

TIPRANKS
·
Aug 05

Eli Lilly Could Swing $65.9 Billion After Earnings

Benzinga
·
Aug 05

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Aug 04

Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly

MT Newswires Live
·
Aug 04

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Reuters
·
Aug 04

Believe it is Medically Appropriate to Make Authentic Retatrutide Available Before FDA Approval for Patients Meeting Some Criteria -Lilly Spokesperson

THOMSON REUTERS
·
Aug 04